Frazier Financial Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$35.5K Sell
412
-128
-24% -$11.3K 0.02% 243
2026
Q2
$42.2K Sell
540
-34
-6% -$2.74K 0.02% 205
2026
Q1
$49.7K Buy
574
+186
+48% +$17.8K 0.03% 186
2025
Q4
$37.3K Buy
388
+1
+0.3% +$97 0.02% 192
2025
Q3
$36.9K Sell
387
-95
-20% -$8.73K 0.02% 190
2025
Q2
$42K Buy
482
+6
+1% +$509 0.03% 171
2025
Q1
$42.8K Buy
476
+19
+4% +$1.7K 0.03% 149
2024
Q4
$36.4K Sell
457
-38
-8% -$3.29K 0.03% 173
2024
Q3
$44.6K Sell
495
-121
-20% -$10.2K 0.03% 148
2024
Q2
$48.5K Buy
616
+4
+0.7% +$328 0.04% 159
2024
Q1
$53.4K Buy
612
+78
+15% +$6.66K 0.04% 147
2023
Q4
$44K Buy
+534
New +$40.7K 0.04% 150

Other funds holding MDT

Frazier Financial Advisors's MDT Position: Q3 2026 in Review

Frazier Financial Advisors reduced its Medtronic (MDT) stake by 24% in Q3 2026, selling an estimated $11.3K and leaving 412 shares worth $35.5K. The position accounts for 0.02% of the portfolio, ranked #243.

Frazier Financial Advisors first reported a position in MDT in Q4 2023 and has held it in 12 quarters since. The position peaked at $53.4K in Q1 2024. 2,178 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Frazier Financial Advisors held 412 shares of Medtronic worth $35.5K as of Q3 2026.
  • Frazier Financial Advisors sold 128 Medtronic shares in Q3 2026, an estimated $11.3K.
  • Medtronic made up 0.02% of Frazier Financial Advisors's portfolio in Q3 2026, its #243 holding.
  • Frazier Financial Advisors first reported a position in Medtronic in Q4 2023 and has held it in 12 quarters since.
  • Frazier Financial Advisors's Medtronic position peaked at $53.4K in Q1 2024.
  • 2,178 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Frazier Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.